Clinical Study Results
How many participants had adverse events?
• 95.8% of participants had adverse events. This was 46 out of 48 participants.
• 20.8% of participants had serious adverse events. This was 10 out of 48 participants.
• 18.8% of participants stopped taking adavosertib because of adverse events. This
was 9 out of 48 participants.
Most common serious adverse events
The most common serious adverse event was nausea.
Most common adverse events
The most common adverse events were diarrhea, nausea, and vomiting.
What medical problems did participants have during
the study?
This section is a summary of the medical problems the participants had during the
study that the study doctors thought might be related to the study drug. These medical
problems are called “adverse reactions”. An adverse reaction is considered “serious”
when it is life-threatening, causes lasting problems, or requires hospital care.
These adverse reactions may or may not be caused by the study drug. A lot of research
is needed to know whether a drug causes an adverse reaction.
The websites listed at the end of this summary may have other information about adverse
reactions or other medical problems that happened during this study.
How many participants had serious adverse reactions?
There were 14.6% of participants who had serious adverse reactions during the study.
This was 7 out of 48 participants.
None of the participants died due to serious adverse reactions during the study. There
were 4 participants who died due to their cancer getting worse.
5